This development will help deliver a long-standing local vision – shared with Barts Life Sciences, a partnership between Queen Mary and the Barts Health NHS Trust, supported by the Barts Charity – to establish East London as an important center of excellence in life sciences. creating high-quality jobs and skills programs and attracting industrial investment from start-ups to multinational corporations. NHS Property Services is a leader in the DHSC project, which involves a planning application and transaction management for the entire cluster.
Queen Mary already has a strong presence in Whitechapel for life sciences research, innovation, education and engagement, as the new facility will increase significantly. This landmark agreement underscores Queen Mary’s commitment to tackling health inequalities at local, national and global levels through world – class research, education and community involvement.
The Queen Mary and Barts Health NHS Trust has a strong and long-lasting partnership that has a track record of delivering life-changing health outcomes, including for communities that are often under-represented in health research and delivery and education. Examples include the East London Genes & Health Study, which has helped identify the genetic determinants of specific diseases, including Covid-19, among Bangladeshi and Pakistani communities.
The continuation of this partnership through Barts Life Sciences and the creation of this new Queen Mary facility will ensure that developments in life sciences research will rapidly lead to improvements in health outcomes for both East London communities and people across the UK. world.
The Minister for Innovation, Lord Kamall, said:
From rapidly creating vaccines to identifying life-saving treatments such as dexamethasone, clinical research has been crucial in our fight against COVID-19 and is crucial in saving thousands of lives.
“It is vital that we continue to build on this innovation to transform our healthcare system to ensure that the NHS is able to provide world – class care.
“This is an important step towards making the Whitechapel Life Sciences Cluster a reality. The partnership between Queen Mary University of London and the Barts Health NHS Trust offers great potential for the future to tackle health inequalities as we build better back from the pandemic.”
Professor Colin Bailey, President and Rector of Queen Mary University of London, said:
“This is a significant day in the history of Queen Mary University of London. Throughout our history, we have driven to improve the health and education outcomes of our communities, and our role in the Whitechapel Life Sciences Cluster is a new chapter in the long history. Our partnership with the Barts Health NHS Trust enables us to deliver world-leading research, education, training and qualifications and life-changing health interventions to one of the most vibrant and diverse communities in the UK.
“The step we have taken today signals one of the greatest research investments in Queen Mary’s history and reinforces our continued commitment to health, well – being and economic success in East London society and to the promotion of world-leading research and education.”
John Biggs, mayor of Tower Hamlets, said:
“The partnership between Queen Mary and the Barts Health NHS Trust to create a Whitechapel Life Sciences Cluster is a major coup for Tower Hamlets. Not only will our residents benefit from better treatments and health outcomes, but the Cluster will create financial opportunities that will also change life.
“By establishing Whitechapel as a major center for the life sciences, the area will attract significant new investment and business opportunities, and most importantly, give our young people the chance to train and develop high-quality careers in the life sciences.
“Whitechapel is steeped in history, making it one of London’s most famous places. We are now creating a new history with major developments, including the new Elizabeth Line station, the renovation of the historic Royal London Hospital building into a new town hall and now a world-class life science center. “
Dame Alwen Williams, Group Chief Executive at the Barts Health NHS Trust, said:
“Congratulations to Queen Mary University of London on this great milestone in the development of the Whitechapel Life Sciences Cluster. I am proud of the long-standing partnership between the Barts Health NHS Trust and the University, where Barts Life Sciences is a perfect illustration of this partnership. working together, we have blended world-leading research with the ability to create health innovations that will work on a large scale in the real world, and in return we have provided vital improvements to the health outcomes of our local communities in East London and beyond to communities across “The new life science facility being developed on this site will help ensure that Barts Life Sciences continues to be a pioneer in healthcare innovation from bench to bedside for decades to come.”
Professor Sir Mark Caulfield, CEO of Barts Life Sciences, said:
“This investment from Queen Mary is a major boost for UK Life Sciences, anchoring the entire Whitechapel Cluster with high-caliber scientific expertise and infrastructure. This ensures that with the Barts Health NHS Trust we can realize the benefits of future health in our Eastern society. London and beyond. “